Selective serotonin reuptake inhibitors (SSRIs) |
Fluoxetine |
Increase extracellular levels of 5-HT |
5-HT inhibits REM sleep-producing cells |
Decreased REM sleep |
Fluvoxamine |
Citalopram |
|
Tricyclic antidepressants |
Amitriptyline |
Increase extracellular levels of 5-HT and NE |
5-HT and NE inhibit REM sleep-producing cells |
Decreased REM sleep |
Nortriptyline |
Clomipramine |
Desipramine |
|
Traditional, amphetamine-like stimulants |
Amphetamine |
Increase extracellular levels of DA and NE |
Increased DA and NE signaling |
Increased wakefulness |
Dextroamphetamine |
Methylphenidate |
|
Wake-promoting, non-traditional stimulants |
Modafinil |
Increase extracellular levels of DA |
Increased DA signaling |
Increased wakefulness |
Armodafinil |
|
Benzodiazepines |
Diazepam |
Enhance GABA signaling via GABAA receptors |
GABA inhibits the arousal systems |
Increased sleep |
Clonazepam |
Lorazepam |
Triazolam |
|
Non-benzodiazepine sedative hypnotics |
Zolpidem |
Enhance GABA signaling via GABAA receptors |
GABA inhibits the arousal systems |
Increased sleep |
Zaleplon |
Zopiclone |
|
Classic antihistamines |
Diphenhydramine |
Block HA H1 receptors |
Reduced HA signaling |
Increased sleep |
Triprolidine |
|
Typical antipsychotics |
Haloperidol |
Block DA receptors |
Reduced DA signaling |
Increased sleep |
Chlorpromazine |